ABIGAIL LOWE: Open Payments
NPI 1073140752 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 22 payments from 14 companies in 2025. Trend: 2023 $317 · 2024 $114 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $88 |
| Janssen Scientific Affairs, LLC | 1 | $76 |
| Viatris Specialty LLC | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| GENZYME CORPORATION | 2 | $43 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Baxter Healthcare | 1 | $24 |
| Grifols USA, LLC | 1 | $23 |
| Philips North America LLC | 1 | $21 |
Products named: DUPIXENT, CARVYKTI, YUPELRI, JASCAYD, LUMRYZ, LEQVIO, Hillrom - Vest System Model 105 Home Care, Prolastin-C Liquid.
Industry payments across VA — which companies pay providers there.
